Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms
- 5 August 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (11), 1389-1398
- https://doi.org/10.1007/s00228-017-2314-3
Abstract
Antipsychotics (APs) are commonly used to manage neuropsychiatric symptoms (NPS) in elderly patients with dementia, even though several large studies have demonstrated an association between AP treatment and increased morbidity and mortality in people with dementia. The aim of this study is to review the scientific literature of the use of AP in the elderly with dementia and to propose an algorithm to assist in decision-making regarding the withdrawal of APs. A computerized literature search (MEDLINE: 1966 to December 2016, EMBASE: 1982 to December 2016) was used to locate relevant literature. Keywords in the search included terms from Medical Subject Headings (MESH) and EMBASE thesaurus (EMTREE). The following terms were used in the MESH database and EMTREE thesaurus: Aged, Antipsychotic Agents, Behavioral Symptoms and Dementia. Earlier studies of APs used in elderly patients with dementia suggest that, in most elderly demented patients, APs can be withdrawn with no effect on behaviour. These patients are likely to benefit from the algorithm we propose to assist clinicians in the withdrawal of APs. In this paper, we review the potential risks and benefits of discontinuing AP treatment in elderly demented patients with NPS and propose an algorithm to assist in decision-making regarding AP withdrawal.Keywords
This publication has 78 references indexed in Scilit:
- Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementiaEmergencias, 2013
- Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care unitsBMC Pharmacology and Toxicology, 2013
- Relapse Risk after Discontinuation of Risperidone in Alzheimer's DiseaseThe New England Journal of Medicine, 2012
- American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2012
- A 6‐month, randomized, double‐blind, placebo‐controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2010
- The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementiaInternational Psychogeriatrics, 2010
- Cerebrovascular Accidents in Elderly People Treated with Antipsychotic DrugsDrug Safety, 2010
- Impact and recognition of cognitive impairment among hospitalized eldersJournal of Hospital Medicine, 2010
- The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: A 12-week open-label pilot studyNeuropsychiatric Disease and Treatment, 2008
- Medication Withdrawal Trials in People Aged 65 Years and OlderDrugs & Aging, 2008